Oral oestrogen therapy

Porphyria cutanea tarda - Oral oestrogen therapy Factor

Last reviewed for CCPS 18 May 2001.

Preliminary questions [30484]

30509 there is some evidence that oral oestrogen therapy may be a factor in the development or worsening of the condition under consideration.

30510 the veteran has undergone a course of oral oestrogen therapy at some time.

30513 — the veteran has established the causal connection between the oral oestrogen therapy and VEA service for porphyria cutanea tarda.

35807 the veteran has undergone a course of oral oestrogen therapy for the 30 days immediately before the clinical onset of the condition under consideration.

30515 — the veteran has established the causal connection between the oral oestrogen therapy and VEA service for the clinical onset of porphyria cutanea tarda.

30518 — the veteran has established the causal connection between the oral oestrogen therapy and operational service for the clinical onset of porphyria cutanea tarda.

or

30519 — the veteran has established the causal connection between the oral oestrogen therapy and eligible service for the clinical onset of porphyria cutanea tarda.

or

7334

the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

7335

the condition under consideration permanently worsened.

35808

the veteran has undergone a course of oral oestrogen therapy for the 30 days immediately before the clinical worsening of the condition under consideration.

30517 — the veteran has established the causal connection between the oral oestrogen therapy and VEA service for the clinical worsening of porphyria cutanea tarda.

30520 — the veteran has established the causal connection between the oral oestrogen therapy and operational service for the clinical worsening of porphyria cutanea tarda.

or

30521 — the veteran has established the causal connection between the oral oestrogen therapy and eligible service for the clinical worsening of porphyria cutanea tarda.

Clinical onset and operational service [30518]

35809

as a causal result of operational service, the veteran underwent a course of oral oestrogen therapy for the 30 days immediately before the clinical onset of the condition under consideration.

or

30512

the veteran was undergoing a course of oral oestrogen therapy for treatment of an illness or injury which is identifiable.

30514

for treatment of the identified illness or injury, the veteran was undergoing a course of oral oestrogen therapy for the 30 days immediately before the clinical onset of the condition under consideration.

30522 — the identified illness or injury for which the course of oral oestrogen therapy was undergone is causally related to operational service.

Clinical onset and eligible service [30519]

35810

as a causal result of eligible service, the veteran underwent a course of oral oestrogen therapy for the 30 days immediately before the clinical onset of the condition under consideration.

or

30512

the veteran was undergoing a course of oral oestrogen therapy for treatment of an illness or injury which is identifiable.

30514

for treatment of the identified illness or injury, the veteran was undergoing a course of oral oestrogen therapy for the 30 days immediately before the clinical onset of the condition under consideration.

30523 — the identified illness or injury for which the course of oral oestrogen therapy was undergone is causally related to eligible service.

Clinical worsening and operational service [30520]

35811

as a causal result of operational service, the veteran underwent a course of oral oestrogen therapy for the 30 days immediately before the clinical worsening of the condition under consideration.

or

30512

the veteran was undergoing a course of oral oestrogen therapy for treatment of an illness or injury which is identifiable.

30516

for treatment of the identified illness or injury, the veteran was undergoing a course of oral oestrogen therapy for the 30 days immediately before the clinical worsening of the condition under consideration.

30522 — the identified illness or injury for which the course of oral oestrogen therapy was undergone is causally related to operational service.

30524

the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury for which the course of oral oestrogen therapy was undergone is causally related.

Clinical worsening and eligible service [30521]

35812

as a causal result of eligible service, the veteran underwent a course of oral oestrogen therapy for the 30 days immediately before the clinical worsening of the condition under consideration.

or

30512

the veteran was undergoing a course of oral oestrogen therapy for treatment of an illness or injury which is identifiable.

30516

for treatment of the identified illness or injury, the veteran was undergoing a course of oral oestrogen therapy for the 30 days immediately before the clinical worsening of the condition under consideration.

30523 — the identified illness or injury for which the course of oral oestrogen therapy was undergone is causally related to eligible service.

30525

the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury for which the course of oral oestrogen therapy was undergone is causally related.